drugset / Trial / NCT00984633

Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED)

NCT00984633

Phase 3 Completed 40 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy, pharmacokinetics, and safety of Org 9426 in maintenance of muscle relaxation in adult subjects undergoing general elective surgery.

Timeline

Start
2003-06
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified 0.6 mg/kg Other
Subject Rocuronium Other / unclassified 0.9 mg/kg Other
Background Propofol Small molecule 4 mg/kg
Background Propofol Small molecule 10 mg/kg
Background Sevoflurane Other / unclassified 0.5 % Intravenous
Background Sevoflurane Other / unclassified 2 % Intravenous

Indications

No indication recorded.